
Hutchinson Cancer Center announced $710.5 million gift to support cancer and infectious disease research, ‘skin-on-chip’ technology
On Oct. 12, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced the Bezos family had committed $710.5 million over the next decade to accelerate the Hutch’s multifaceted approach to scientific discovery. The gift supports the organization’s efforts to dramatically accelerate the pace and breadth of medical breakthroughs in cancer and infectious disease by tapping the full potential of today’s science. Organizational leaders expect these efforts to require $3 billion in philanthropic support over the next decade and believe this gift will inspire additional donor support.
This is the second transformational donor commitment made to Fred Hutch in the past two months; a gift of $78 million from Stuart and Molly Sloan was announced in September. Both gifts follow the recent merger that united Fred Hutch — a top scientific research center — with clinical care partner Seattle Cancer Care Alliance. Fred Hutch, an independent organization, now serves as UW Medicine’s cancer program.
The landmark gift builds on previous Bezos family funding for research in immunotherapy treatments using the body’s own immune system to attack cancerous or diseased cells. Fred Hutch is a world leader in developing immunotherapies and prior support from the family led to the opening of a first-of-its-kind, patient-centered clinic to provide novel cell therapies to people with a variety of cancers.
Tags:
Source: Fred Hutchinson Cancer Research Center
Credit:
